Showing results (71-80 of 154) with videos related to
Sort By:
Pageof 16
Parkinsonism & Related Disorders|September 29, 2009
Olfaction and apathy in Parkinson's diseaseChristina K Cramer, Joseph H Friedman, Melissa M AmickMovement Disorders : Official Journal of the Movement Disorder Society|December 16, 2003
REM behavior disorder and excessive daytime somnolence in Machado-Joseph disease (SCA-3)Joseph H Friedman, Hubert H Fernandez, Lewis R SudarskyMovement Disorders : Official Journal of the Movement Disorder Society|July 16, 2004
Long-term outcome of clozapine use for psychosis in parkinsonian patientsHubert H Fernandez, Edward M Donnelly, Joseph H FriedmanClinical Neuropharmacology|April 20, 2004
Aripiprazole for drug-induced psychosis in Parkinson disease: preliminary experienceHubert H Fernandez, Martha E Trieschmann, Joseph H FriedmanThe Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 6, 2006
CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acidKylie A Scoggan, Joseph H Friedman, Dennis E BulmanCNS Spectrums|July 4, 2006
Non-motor aspects of Parkinson's diseaseLeora L Borek, Melissa M Amick, Joseph H FriedmanRhode Island Medical Journal (2013)|July 26, 2024
Autopsy-Proven "Pure" Parkinson's Disease with Rapidly Progressive Dementia and Cognitive Fluctuations in a Patient with GBA MutationNahid Mohammadzadeh, Michael Punsoni, Saud Alhusaini, et al.Drug Safety|June 20, 2003
Treatment of psychosis in Parkinson's disease: safety considerationsHubert H Fernandez, Martha E Trieschmann, Joseph H FriedmanExpert Opinion on Pharmacotherapy|May 3, 2007
The management of psychosis in movement disorder patientsKelvin L Chou, Leora L Borek, Joseph H FriedmanMovement Disorders : Official Journal of the Movement Disorder Society|October 3, 2002
Executive and emotional dysfunction in Machado-Joseph diseaseTricia M Zawacki, Janet Grace, Joseph H Friedman, et al.Pageof 16